These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14532169)

  • 21. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
    DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs.
    Ogihara N; Ebihara S; Kawamura W; Okamoto M; Sakai T; Takiguchi K; Morita T; Uchida R; Matsuyama Y; Hayashi Y; Arakawa Y; Kikuchi M
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E148-55. PubMed ID: 12388150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.
    Moore MC; DiCostanzo CA; Dardevet D; Lautz M; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E556-63. PubMed ID: 15522992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.
    Myers SR; Biggers DW; Neal DW; Cherrington AD
    J Clin Invest; 1991 Jul; 88(1):158-67. PubMed ID: 2056115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
    J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.
    Holste LC; Connolly CC; Moore MC; Neal DW; Cherrington AD
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E488-96. PubMed ID: 9316437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs.
    Adkins-Marshall B; Pagliassotti MJ; Asher JR; Connolly CC; Neal DW; Williams PE; Myers SR; Hendrick GK; Adkins RB; Cherrington AD
    Am J Physiol; 1992 May; 262(5 Pt 1):E679-86. PubMed ID: 1590377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization.
    Johnson PM; Chen SS; Santomango TS; Williams PE; Lacy DB; McGuinness OP
    Metabolism; 2011 Jun; 60(6):867-73. PubMed ID: 20940071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin.
    Winnick JJ; An Z; Moore MC; Ramnanan CJ; Farmer B; Shiota M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E358-66. PubMed ID: 19470836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose.
    Camacho RC; Lacy DB; James FD; Coker RH; Wasserman DH
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E269-74. PubMed ID: 15053988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
    Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.
    Myers SR; McGuinness OP; Neal DW; Cherrington AD
    J Clin Invest; 1991 Mar; 87(3):930-9. PubMed ID: 1999501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon chronically impairs hepatic and muscle glucose disposal.
    Chen SS; Zhang Y; Santomango TS; Williams PE; Lacy DB; McGuinness OP
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E928-35. PubMed ID: 17132827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative parenteral nutrition while proactively minimizing insulin resistance.
    Svanfeldt M; Thorell A; Nygren J; Ljungqvist O
    Nutrition; 2006 May; 22(5):457-64. PubMed ID: 16473497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis.
    Moore MC; Rossetti L; Pagliassotti MJ; Monahan M; Venable C; Neal D; Cherrington AD
    Am J Physiol; 1996 Aug; 271(2 Pt 1):E215-22. PubMed ID: 8770013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.